Aquavit appoints new chief medical technology officer
This article was originally published in Scrip
Aquavit Pharmaceuticals, a company using desktop compounding technology for personalized medicine development, has appointed Dr David Shafer chief medical technology officer. Prior to joining New York, US-based Aquavit Dr Shafer launched the first Vectra XT 3D Imaging System, which allows patients view a 3D stimulation of a procedure on their body prior to surgery. He also created the first plastic surgery iPhone app. Dr Shafer will be responsible for R&D medical technology for Aquavit's product pipeline.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.